Open labelled, single arm, retrospective study of oral tofacitinib in vitiligo
Not Applicable
Completed
- Conditions
- Health Condition 1: L80- Vitiligo
- Registration Number
- CTRI/2023/01/048849
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
1. All clinically diagnosed cases of different variants of vitiligo
2.Patients who were started on oral tofacitinib for vitiligo
Exclusion Criteria
•Patients receiving other systemic immunosuppressive drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method